Clinical and Translational Science Center

临床和转化科学中心

• 批准号: 10213868
• 负责人: JULIANNE L IMPERATO-MCGINLEY
• 金额: $ 769.11万
• 依托单位: WEILL MEDICAL COLL OF CORNELL UNIV
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-09-05 至 2022-07-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10213868
• 关键词: Accountability; Address; Animals; Area; Basic Science; Biomedical Engineering; Center for Translational Science Activities; Characteristics; Child; Clinical; Clinical Management; Clinical Research; Clinical Sciences; Clinical Trials; Collaborations; Complex; Development; Education; Ensure; Environment; Ethics; Evaluation; Fostering; Foundations; Home; Human; Individual; Industry Standard; Institutes; Institution; Lead; Leadership; Medical Research; Medical center; Medicine; Memorial Sloan-Kettering Cancer Center; Methods; Minority-Serving Institution; Needs Assessment; Operative Surgical Procedures; Patient Care; Performance; Pilot Projects; Positioning Attribute; Process; Recommendation; Rehabilitation therapy; Reporting; Research; Research Institute; Research Training; Resources; School Nursing; Schools; Special Hospitals; Standardization; Structure; System; Training; Training and Education; Translational Research; Universities; Veterinary Medicine; base; cohesion; college; community organizations; design; experimental study; fundamental research; improved; innovation; member; nanobiotechnology; programs; quality assurance; recruit; response; synergism; tool; urban public health; urban school

A. ADMINISTRATIVE CORE PROJECT SUMMARY/ABSTRACT During the past ten years the Weill Cornell Clinical and Translational Science Center (CTSC) has established an inclusive, strong and highly effective governance structure incorporating our partners as active members. As lead institution, Weill Cornell Medicine (WCM) serves as an academic home through which essential resources, technological tools and education programs can be efficiently shared and managed. The partner institutions comprising the CTSC are also neighbors located on York Avenue “The Translational Research Avenue”. Within the immediate area are: Memorial Sloan Kettering Cancer Center (MSK); Hospital for Special Surgery (HSS); Hunter College (HC), School of Nursing (HCSON) and its Center for Translational and Basic Research (CTBR)/Research Center for Minority Institutions (RCMI), School of Urban Public Health; and the Animal Medical Center. In addition to this partnership, the CTSC has extensive ties to both Cornell University, Ithaca (CU) (particularly with the Nanobiotechnology Center, the Schools of Bioengineering and Veterinary Medicine), The McGovern Center for Venture Development and to the Burke Medical Research Institute for Rehabilitation, White Plains NY. The resulting cluster of institutions forms a unique and cohesive biomedical complex fulfilling the NCATS roadmap initiative of breaking-down institutional and disciplinary silos to accelerate translational research. Individually, the partner institutions are superb centers of intellectual and academic excellence. Their integration into the CTSC harnesses their distinctive characteristics, hastening clinical and translational research breakthroughs for improved patient care. The CTSC Administrative Core is tightly integrated with Evaluation and Continuous Improvement and Quality and Efficiency. Administration oversees the management of the CTSC, including introduction of the Balanced Scorecard approach. Evaluation and Tracking accomplishes the assessment of translational research and training innovations, introducing in this cycle the integration of the Results Based Accountability framework central to CTSA Common metrics, and the idea of targeted micro- experiments that can lead to multi-hub pilot studies and eventual impact on the CTSA network and the field. The Quality and Efficiency section enhances trial efficiency and recruitment through the introduction of a CTSC Performance Management Team. The Performance Management Team (PMT) will be the mechanism by which the CTSC improves research process performance. It will incorporate both the Balanced Scorecard approach used by the AC and the Results-Based Accountability approach that is the foundation of the CTSA Common Metrics effort.

A.行政核心 项目摘要/摘要 在过去的十年中 一种包容性，强大且高效的治理结构，将我们的合作伙伴作为活跃成员。作为 领导机构Weill Cornell Medicine（WCM）是一个学术家 可以有效地共享和管理技术工具和教育计划。合作伙伴机构 由CTSC组成的邻居也位于约克大街的“转化研究大道”。之内 附近的区域是：纪念Sloan Kettering癌症中心（MSK）；特殊外科医院（HSS）； 亨特学院（HC），护理学院（HCSON）及其转化和基础研究中心 （CTBR）/城市公共卫生学院的少数民族机构研究中心（RCMI）；和动物医疗 中心。除了这种合作伙伴关系外，CTSC与康奈尔大学（CU）都有广泛的联系 （部分地在纳米元学中心，生物工程和兽医学院）， 麦戈文风险发展中心和伯克医学研究所康复研究所，白色 平原纽约。由此产生的机构组成了一个独特而有凝聚力的生物医学络合物，使得 NCATS路线图的损坏机构和纪律孤岛的倡议加速转化 研究。单独，合作伙伴机构是智力和学术卓越的出色中心。他们的 集成到CTSC中，利用其独特的特征，加快临床和翻译研究 改善患者护理的突破。 CTSC管理核心与评估紧密整合 以及持续的改进，质量和效率。政府监督管理 CTSC，包括引入平衡记分卡方法。评估和跟踪完成 评估翻译研究和培训创新，在此周期中引入 基于结果的责任框架是CTSA共同指标的中心，以及针对性的微观的想法 可以导致多中心试验研究并最终对CTSA网络和领域的影响的实验。 质量和效率部分通过引入CTSC提高了试验效率和招聘 绩效管理团队。绩效管理团队（PMT）将是该机制 CTSC改善了研究过程的性能。它将结合平衡的记分卡方法 AC使用和基于结果的责任方法是CTSA Common的基础 指标努力。